Gyermekkori daganatok: vizsgálatok itt: Szingapúr
19 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Singapore
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Singapore
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1/2. fázisTaking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Kent Ridge, Singapore
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Singapore
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - No phaseTaking peopleDeveloping and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program
- Where
- Singapore
- Életkor
- 16 év and over
- People
- 280
- Run by
- National University Hospital, Singapore
See details and how to joinNCT07247123 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleIndividualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 5500
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT02806388 - 3. fázisTaking peopleONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
- Where
- Singapore
- People
- 510 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00 - 1/2. fázisTaking peopleAntigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
- Where
- Singapore
- Életkor
- 10 év to 80 év
- People
- 30
- Run by
- National University Hospital, Singapore
See details and how to joinNCT07319676 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleRandomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
- Where
- Singapore
- Életkor
- 21 hónap to 99 év
- People
- 50
- Run by
- National University Hospital, Singapore
See details and how to joinNCT05305131 - 2. fázisTaking peopleA Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- Where
- Singapore
- Életkor
- 6 hónap to 25 év
- People
- 141 worldwide
- Run by
- Day One Biopharmaceuticals, Inc.
See details and how to joinNCT04775485 · EU 2024-510691-20-00 - No phaseTaking peopleOutcomes of a Novel Technique Minimal Scar Mastectomy
- Where
- Singapore
- People
- 100
- Run by
- KK Women's and Children's Hospital
See details and how to joinNCT06676761 - 2. fázisTaking peopleMa-Spore ALL 2020 Study
- Where
- Singapore
- Életkor
- Up to 40 év
- People
- 500 worldwide
- Run by
- National University Hospital, Singapore
See details and how to joinNCT06336395 - 2. fázisTaking peopleCD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
- Where
- Singapore
- Életkor
- 0 év to 70 év
- People
- 40
- Run by
- KK Women's and Children's Hospital
See details and how to joinNCT05648019